(Q44259214)

1 December 2017

title

Subchronic continuous phencyclidine administration potentiates amphetamine-induced frontal cortex dopamine release (English)

1 reference

1 December 2017

0 references

5

Daniel C Javitt

1 reference

1 December 2017

Andrea Balla

1

1 reference

1 December 2017

Henry Sershen

series ordinal

2

1 reference

1 December 2017

Michael Serra

series ordinal

3

1 reference

1 December 2017

Rajeth Koneru

series ordinal

4

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

1 December 2017

published in

Neuropsychopharmacology

1 reference

1 December 2017

volume

28

1 reference

1 December 2017

issue

1

1 reference

1 December 2017

page(s)

34-44

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300019

1 December 2017

exact match

0 references

cites work

Alterations of benzodiazepine receptors in type II alcoholic subjects measured with SPECT and [123I]iomazenil.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

A longitudinal study of symptom dimensions in schizophrenia. Prediction and patterns of change.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

Phencyclidine-induced dysregulation of dopamine response to amphetamine in prefrontal cortex and striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

Continuous phencyclidine treatment induces schizophrenia-like hyperreactivity of striatal dopamine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

The current status of the dopamine hypothesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

Anatomical analysis of the involvement of mesolimbocortical dopamine in the locomotor stimulant actions of d-amphetamine and apomorphine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

A theory of dopamine function and its role in cognitive deficits in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

Recovery of neuropsychological functions during reduction in use of phencyclidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

NMDA receptors in nucleus accumbens modulate stress-induced dopamine release in nucleus accumbens and ventral tegmental area.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

Effects of medial prefrontal cortical injections of GABA receptor agonists and antagonists on the local and nucleus accumbens dopamine responses to stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

MK-801 increases locomotor activity without elevating extracellular dopamine levels in the nucleus accumbens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

Subchronically applied phencyclidine fails to disrupt prepulse inhibition in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

Phencyclidine-induced locomotor activity in the rat is blocked by 6-hydroxydopamine lesion of the nucleus accumbens: Comparisons to other psychomotor stimulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

Functional and anatomical aspects of prefrontal pathology in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

Gating of information flow within the limbic system and the pathophysiology of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

The Iowa Longitudinal Study of Recent Onset Psychosis: one-year follow-up of first episode patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

Evidence for involvement of N-methyl-D-aspartate receptor in tonic inhibitory control of dopaminergic transmission in rat medial frontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

Effect of phencyclidine on dopamine release in the rat prefrontal cortex; an in vivo microdialysis study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

A review of the nonmedical use of ketamine: use, users and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

A.E. Bennett Research Award. Reversal of phencyclidine-induced effects by glycine and glycine transport inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

Recent advances in the phencyclidine model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

Subchronic phencyclidine administration increases mesolimbic dopaminergic system responsivity and augments stress- and psychostimulant-induced hyperlocomotion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

Prefrontal cortical involvement in phencyclidine-induced activation of the mesolimbic dopamine system: behavioral and neurochemical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

Effects of phencyclidine on behavior and extracellular levels of dopamine and its metabolites in neonatal ventral hippocampal damaged rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

NMDA receptors mediate the behavioral effects of amphetamine infused into the nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

Effects of selective dopamine depletion in medial prefrontal cortex on basal and evoked extracellular dopamine in neostriatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

Loss of dopamine terminals in the medial prefrontal cortex increased the ratio of DOPAC to DA in tissue of the nucleus accumbens shell: role of stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

Behavioural, pharmacological and biochemical effects of acute and chronic administration of ketamine in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

Increased dopamine transmission in schizophrenia: relationship to illness phases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

Differential effects of single and repeated ketamine administration on dopamine, serotonin and GABA transmission in rat medial prefrontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

Effects of sustained phencyclidine exposure on sensorimotor gating of startle in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

Increases in extracellular dopamine levels and locomotor activity after direct infusion of phencyclidine into the nucleus accumbens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

Effect of lesions in the striatum, nucleus accumbens and medial raphe on phencyclidine-induced stereotyped behaviors and hyperactivity in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

Differential effects of phencyclidine and methamphetamine on dopamine metabolism in rat frontal cortex and striatum as revealed by in vivo dialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

Cognitive correlates of the negative, disorganized, and psychotic symptom dimensions of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

Locomotor activation induced by MK-801 in the rat: postsynaptic interactions with dopamine receptors in the ventral striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

The reduced neuropil hypothesis: a circuit based model of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

Longitudinal assessment of methylphenidate effects on oral word production and symptoms in first-episode schizophrenia at acute and stabilized phases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

Glutamate receptor agonists decrease extracellular dopamine in the rat nucleus accumbens in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

Target-specific glutamatergic regulation of dopamine neurons in the ventral tegmental area

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

Chronic phencyclidine increases NMDA receptor NR1 subunit mRNA in rat forebrain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

MK-801 does not prevent acute stimulatory effects of amphetamine or cocaine on locomotor activity or extracellular dopamine levels in rat nucleus accumbens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

Involvement of gamma-aminobutyric acid neurotransmission in phencyclidine-induced dopamine release in the medial prefrontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

7 January 2021

The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

7 January 2021

Meta-analysis of symptom factors in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

7 January 2021

Regulation of NMDA-stimulated [14C]GABA and [3H]acetylcholine release by striatal glutamate and dopamine receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

7 January 2021

The prefrontal cortex regulates the basal release of dopamine in the limbic striatum: an effect mediated by ventral tegmental area.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

7 January 2021

Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

7 January 2021

Dextroamphetamine enhances "neural network-specific" physiological signals: a positron-emission tomography rCBF study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

7 January 2021

Effects of MK-801 on spontaneous and amphetamine-stimulated dopamine release in striatum measured with in vivo microdialysis in awake rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

7 January 2021

Effects of continuous D-amphetamine and phencyclidine administration on social behaviour, stereotyped behaviour, and locomotor activity in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

7 January 2021

Electrophysiological characterization of GABAergic neurons in the ventral tegmental area.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

7 January 2021

Glutamatergic regulation of basal and stimulus-activated dopamine release in the prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

7 January 2021

In vivo stimulated dopamine release in the nucleus accumbens: modulation by the prefrontal cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

7 January 2021

Quantitation of Phencyclidine in Serum by Enzyme Immunoassay: Results in 405 Patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300019

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300019

1 reference

1 December 2017

1 reference